Stock Markets February 9, 2026

Warpaint London buys Barry M brand for £1.4m, excludes manufacturing and liabilities

Acquisition from administration covers IP, stock and order book; Warpaint flags modest revenue growth for 2025 and higher cash balances

By Avery Klein
Warpaint London buys Barry M brand for £1.4m, excludes manufacturing and liabilities

Warpaint London has agreed to acquire the Barry M cosmetics brand for £1.4 million in cash, subject to court approval expected Monday. The purchase, completed out of administration, includes Barry M’s intellectual property, inventory and order book but explicitly excludes manufacturing capabilities and liabilities. Warpaint also issued a trading update for the year ended December 31, 2025, forecasting roughly £105 million of revenue and adjusted EBITDA of about £22 million, and reported a cash balance of £18 million as of January 31, 2026.

Key Points

  • Warpaint is acquiring Barry M’s IP, stock and order book for £1.4 million in cash - cosmetics and retail sectors affected.
  • Barry M had around £15 million of revenue for the year ended February 28, 2025 and maintains shelf presence in over 1,300 outlets, including major UK chains and Australian Priceline stores - retail distribution footprint is significant.
  • Warpaint expects 2025 revenue of approximately £105 million and adjusted EBITDA near £22 million, with cash balances of £18 million as of January 31, 2026 - corporate finance and AIM-listed equity impacted.

Warpaint London PLC has agreed to buy the Barry M cosmetics brand for £1.4 million in cash, a deal that remains conditional on court approval expected Monday. The transaction acquires Barry M’s intellectual property, current stock and its order book; manufacturing assets and any liabilities are not part of the purchase.

Barry M is being acquired from administration. For the year ended February 28, 2025, the brand recorded approximately £15 million in revenue.


Distribution footprint

Barry M retains a substantial retail presence across multiple chains, with one-meter-plus stands in more than 1,300 outlets. That footprint includes about 650 Superdrug locations, 420 Boots stores, 120 Sainsbury’s outlets, 50 Tesco stores and roughly 90 Priceline stores in Australia.


Group trading update for 2025

Separately, Warpaint provided a trading update covering the year ended December 31, 2025. The company said it expects group revenue of around £105 million, up from £102 million in 2024. Warpaint noted improved gross margins during the period and said the 2025 top-line reflects a £12 million revenue contribution from Brand Architekts, which Warpaint acquired in February 2025.

Adjusted EBITDA for 2025 is projected to be about £22 million, compared with £25 million in 2024. The update specified that Brand Architekts added approximately £0.8 million to adjusted EBITDA in 2025, versus an approximate £1 million loss in 2024.

The company quantified headwinds to revenue in 2025. These included the closure of Bodycare, which reduced revenue by about £3 million; a challenging consumer environment that subtracted roughly £4 million; and business lost as a result of US tariff uncertainty, which Warpaint estimated at about £2 million.


Financial position and outlook

Warpaint reported cash balances of £18 million as of January 31, 2026, up from £9 million a year earlier.

On future expectations the chief executive said: "Looking ahead to the new year, we expect to see a return to organic growth across the Group and also expect to be able to update the market on further significant new customer roll outs with our full year results in April."

The Barry M purchase, the company clarified, excludes manufacturing capabilities and liabilities, and remains subject to the required court sanction. Additional integration details and the treatment of any excluded liabilities were not provided in the trading update.


Implications

The deal secures a recognised value cosmetics brand with an established retail footprint while avoiding acquisition of manufacturing operations and certain liabilities. Warpaint’s trading update points to modest revenue growth for 2025, a decline in adjusted EBITDA year on year, and a materially stronger cash position as of late January 2026.

Risks

  • Acquisition remains conditional on court approval expected Monday - legal approval uncertainty affects completion timing and integration.
  • Purchase excludes manufacturing capabilities and liabilities, which could complicate operational integration or require future arrangements - operational risk for the cosmetics and manufacturing sectors.
  • Revenue in 2025 was negatively affected by Bodycare closure (approx. £3 million), a challenging consumer environment (approx. £4 million) and US tariff uncertainty (approx. £2 million) - consumer spending and trade policy risk to retail and consumer goods sectors.

More from Stock Markets

Asian Markets Muted as U.S. Tariff Moves Keep Investors Cautious Feb 22, 2026 Regis Healthcare Shares Jump After Solid First-Half Results Feb 22, 2026 Samsung Shares Surge to Record on Report It Could Be Nvidia's Exclusive HBM4 Supplier Feb 22, 2026 Microsoft gaming leadership reshuffled as Phil Spencer retires and Asha Sharma named CEO Feb 22, 2026 U.S. Futures Slide as Trump Moves to Reapply Tariffs Under Alternate Law; Nvidia Results in Focus Feb 22, 2026